Who we are

Allan Wehnert (CEO/SCO) has been working in the pharmaceutical industry for more than 30 years and has been involved with all phases of drug development focusing on discovering and developing new molecules for treatment of diseases in the central nervous system. He is a trained pharmacologist and has been the author of 25 scientific papers published in highly accredited international journals. 

Allan currently holds a position as senior vice president for research and development at Initiator Pharma, advisor for private equity syndicate and is the owner of Decision Insights. During his career Allan served as Senior Vice President at Lundbeck for 25 years and was responsible for developing drugs from late pre-clinical till NDA/EMA approval. Allan was member of the executive management group at Lundbeck A/S. During that time that Allan worked for Lundbeck the R&D organisation brought 6 products to the market and Allan had oversight more than 75 due diligence processes and more than 7 asset and company acquisitions.

Allan Wehnert:

Phone: +45 5384 2743
Email: awe@alteraltx.com

Learn more about Allan